This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Apr Applied Pharma Research Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Wagstaff and Sapropterin Formulation Innovation.
Introduction.
Christopher Wagstaff is an inventor associated with Cambridge, Great Britain. His listed patent work concerns a formulation of sapropterin, a pharmaceutical compound, and describes a solid suspension of sapropterin dispersed within an oil.
Latest Patents.
Wagstaff is associated with 1 patent: “Sapropterin formulation.” The disclosure describes the oil-based suspension and also contemplates methods of treatment using the formulation.
Career Highlights.
Wagstaff is associated with APR Applied Pharma Research SA. His patent work reflects an interest in pharmaceutical formulation and potential therapeutic applications.
Collaborations.
Stephen Tickle is listed as Wagstaff’s coworker, indicating a professional connection in the context of their pharmaceutical work.
Conclusion.
Christopher Wagstaff’s recorded innovation centers on an oil-dispersed sapropterin formulation and its potential use in treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile